• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗斯伯里氏菌刺激 TLR5 依赖性肠道免疫以对抗克罗恩病。

Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn's disease.

机构信息

Department of Gastroenterology, The Third Xiangya Hospital, Central South University Changsha, Hunan 410013, PR China; Hunan Key Laboratory of Non-resolving Inflammation and Cancer, Changsha, Hunan 410008, PR China; Cancer Research Institute of Central South University, Changsha, Hunan 410008, PR China.

Department of Gastroenterology, The Third Xiangya Hospital, Central South University Changsha, Hunan 410013, PR China.

出版信息

EBioMedicine. 2022 Nov;85:104285. doi: 10.1016/j.ebiom.2022.104285. Epub 2022 Sep 28.

DOI:10.1016/j.ebiom.2022.104285
PMID:36182776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9526137/
Abstract

BACKGROUND

Crohn's disease (CD) is a chronic inflammatory disorder characterized by intestinal immune dysfunction. Multiple factors, including gut dysbiosis, are involved in the pathogenesis of CD. However, the effect of commensal bacteria on controlling the inflammatory response in individuals with CD remains unclear.

METHODS

We detected Toll-like receptor 2 (TLR2), TLR4, and TLR5 expression in Roseburia intestinalis (R. intestinalis)-treated mice with 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis. Then, we quantified the signs of colonic inflammation, the proportion of regulatory T cells (Tregs) and the expression of thymic stromal lymphopoietin (TSLP) and transforming growth factor (TGF)-β in TLR-5-deficient (Tlr5) mice, bone marrow chimera mice (generated using wild-type (WT) and Tlr5 mice), and anti-TSLP/anti-TGFβ-treated C57BL/6 mice with colitis induced by TNBS. In vitro, we used the lipopolysaccharide (LPS)-stimulated human intestinal epithelial cell line Caco-2 as an inflammatory colon cell model treated with or without the TLR5-siRNA intervention in the presence of R. intestinalis and incubated human monocyte-derived dendritic cells (DCs) with the supernatant of Caco-2 cells. Then, we cocultured human CD4 T cells with the aforementioned DCs to determine the differentiation of Tregs. Additionally, samples from patients with CD were collected to analyse the correlation between TLR5/TSLP/TGFβ expression and the percentage of R. intestinalis.

FINDINGS

Here, we show that R. intestinalis inhibits the development of CD by increasing the differentiation of anti-inflammatory Tregs. Mechanistically, R. intestinalis stimulates TSLP production in intestinal epithelial cells (IECs) through TLR5 but not TLR2 or TLR4. TSLP produced by IECs specifically induces the secretion of interleukin-10 (IL-10) and TGFβ from DCs, which is necessary for subsequent Treg differentiation. Consequently, the depletion of TLR5 (using Tlr5 mice) or inhibition of TSLP (using anti-TSLP neutralizing antibodies) attenuates the protective effect of R. intestinalis on experimental colitis in mice. Importantly, the expression of TSLP in patients with CD is positively correlated with the level of R. intestinalis.

INTERPRETATION

These findings reveal the previously unknown mechanism of R. intestinalis-mediated intestinal immune regulation, which may provide the basis for new therapeutic strategies for CD.

FUNDING

This work was funded by the National Natural Science Foundation of China (81670504 and 81970494), the Key Project of Research and Development Plan of Hunan Province (2019SK2041) and the Changsha Municipal Natural Science Foundation (kq2014258).

摘要

背景

克罗恩病(CD)是一种以肠道免疫功能障碍为特征的慢性炎症性疾病。多种因素,包括肠道菌群失调,参与了 CD 的发病机制。然而,共生菌对控制 CD 患者炎症反应的影响尚不清楚。

方法

我们检测了 2,4,6-三硝基苯磺酸(TNBS)诱导结肠炎的罗斯伯里氏菌(R. intestinalis)处理的 TLR2、TLR4 和 TLR5 在小鼠中的表达。然后,我们在 TLR5 缺陷(Tlr5)小鼠、骨髓嵌合体小鼠(由野生型(WT)和 Tlr5 小鼠生成)和用 TNBS 诱导结肠炎的抗 TSLP/抗 TGFβ 处理的 C57BL/6 小鼠中定量评估结肠炎症的迹象、调节性 T 细胞(Tregs)的比例以及胸腺基质淋巴生成素(TSLP)和转化生长因子(TGF)-β的表达。在体外,我们使用脂多糖(LPS)刺激的人肠道上皮细胞系 Caco-2 作为炎症性结肠细胞模型,在存在 R. intestinalis 的情况下用或不用 TLR5-siRNA 干预,并将人单核细胞衍生的树突状细胞(DCs)与 Caco-2 细胞的上清液共培养。然后,我们将人 CD4 T 细胞与上述 DC 共培养,以确定 Tregs 的分化。此外,还收集了 CD 患者的样本,以分析 TLR5/TSLP/TGFβ 表达与 R. intestinalis 百分比之间的相关性。

结果

在这里,我们表明 R. intestinalis 通过增加抗炎性 Tregs 的分化来抑制 CD 的发展。在机制上,R. intestinalis 通过 TLR5 而不是 TLR2 或 TLR4 刺激肠道上皮细胞(IECs)中 TSLP 的产生。IECs 产生的 TSLP 特异性诱导 DC 分泌白细胞介素-10(IL-10)和 TGFβ,这对于随后的 Treg 分化是必要的。因此,TLR5 的耗竭(使用 Tlr5 小鼠)或 TSLP 的抑制(使用抗 TSLP 中和抗体)减弱了 R. intestinalis 对小鼠实验性结肠炎的保护作用。重要的是,CD 患者 TSLP 的表达与 R. intestinalis 的水平呈正相关。

结论

这些发现揭示了 R. intestinalis 介导的肠道免疫调节的先前未知机制,这可能为 CD 的新治疗策略提供依据。

资金来源

本工作得到了国家自然科学基金(81670504 和 81970494)、湖南省重点研发计划(2019SK2041)和长沙市自然科学基金(kq2014258)的资助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/cb8845f02685/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/8acbc9441d88/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/d27b908ad659/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/94080961e7e3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/2b0dc1b78b82/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/1331ff031838/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/02a0bc0dd54f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/cb8845f02685/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/8acbc9441d88/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/d27b908ad659/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/94080961e7e3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/2b0dc1b78b82/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/1331ff031838/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/02a0bc0dd54f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710e/9526137/cb8845f02685/gr7.jpg

相似文献

1
Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn's disease.罗斯伯里氏菌刺激 TLR5 依赖性肠道免疫以对抗克罗恩病。
EBioMedicine. 2022 Nov;85:104285. doi: 10.1016/j.ebiom.2022.104285. Epub 2022 Sep 28.
2
Insights into Roseburia intestinalis which alleviates experimental colitis pathology by inducing anti-inflammatory responses.深入了解玫瑰色双歧杆菌通过诱导抗炎反应缓解实验性结肠炎病理的机制。
J Gastroenterol Hepatol. 2018 Oct;33(10):1751-1760. doi: 10.1111/jgh.14144. Epub 2018 May 7.
3
and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway.并通过 SP3 信号通路抑制结肠炎和上调 TLR5。
Nutrients. 2022 Jul 25;14(15):3041. doi: 10.3390/nu14153041.
4
inhibits oncostatin M and maintains tight junction integrity in a murine model of acute experimental colitis.在急性实验性结肠炎小鼠模型中抑制制瘤素M并维持紧密连接完整性。
Scand J Gastroenterol. 2019 Apr;54(4):432-440. doi: 10.1080/00365521.2019.1595708. Epub 2019 Apr 4.
5
hUC-MSCs therapy for Crohn's disease: efficacy in TNBS-induced colitis in rats and pilot clinical study.hUC-MSCs 治疗克罗恩病:在三硝基苯磺酸诱导的大鼠结肠炎中的疗效和初步临床研究。
EBioMedicine. 2024 May;103:105128. doi: 10.1016/j.ebiom.2024.105128. Epub 2024 Apr 22.
6
Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model.重组乳酸菌在肠道黏膜水平递送TSLP对葡聚糖硫酸钠诱导的结肠炎小鼠模型的保护作用。
Microb Cell Fact. 2015 Nov 6;14:176. doi: 10.1186/s12934-015-0367-5.
7
The JNK/P38 signalling pathway activated by testin protects the intestinal epithelial barrier against Crohn's disease-like colitis.测试蛋白激活的 JNK/P38 信号通路可保护肠道上皮屏障免受类克罗恩病结肠炎的侵害。
Chem Biol Interact. 2024 Nov 1;403:111222. doi: 10.1016/j.cbi.2024.111222. Epub 2024 Sep 4.
8
Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis.肠道罗斯伯里菌抑制白细胞介素-17 的分泌并促进结肠炎中调节性 T 细胞的分化。
Mol Med Rep. 2018 Jun;17(6):7567-7574. doi: 10.3892/mmr.2018.8833. Epub 2018 Mar 29.
9
MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease.微小RNA-124通过靶向芳烃受体促进克罗恩病中的肠道炎症
J Crohns Colitis. 2016 Jun;10(6):703-12. doi: 10.1093/ecco-jcc/jjw010. Epub 2016 Jan 22.
10
Magnolin inhibits intestinal epithelial cell apoptosis alleviating Crohn's disease-like colitis by suppressing the PI3K/AKT signalling pathway.木兰碱通过抑制 PI3K/AKT 信号通路抑制肠道上皮细胞凋亡,缓解克罗恩病样结肠炎。
Int Immunopharmacol. 2024 Jun 15;134:112181. doi: 10.1016/j.intimp.2024.112181. Epub 2024 May 10.

引用本文的文献

1
Membrane vesicles produced by next-generation probiotics from the gut as innovative tools for human health.肠道新一代益生菌产生的膜泡作为促进人类健康的创新工具。
Gut Microbes. 2025 Dec;17(1):2552344. doi: 10.1080/19490976.2025.2552344. Epub 2025 Sep 1.
2
Gut microbiome dysbiosis accelerates osteoarthritis progression by inducing IFP-SM inflammation in "double-hit" mice.肠道微生物群失调通过在“双打击”小鼠中诱导IFP-SM炎症加速骨关节炎进展。
Arthritis Res Ther. 2025 Jul 7;27(1):137. doi: 10.1186/s13075-025-03602-y.
3
IL-17A as a Key Mediator of Pulmonary-Intestinal Immune Interactions in a Mouse Model of Asthma and Colitis.
白细胞介素-17A作为哮喘和结肠炎小鼠模型中肺-肠免疫相互作用的关键介质
J Inflamm Res. 2025 Jun 21;18:8199-8216. doi: 10.2147/JIR.S512605. eCollection 2025.
4
Modulates Immune Responses by Inducing M1 Macrophage Polarization.通过诱导M1巨噬细胞极化来调节免疫反应。
Int J Mol Sci. 2025 May 23;26(11):5049. doi: 10.3390/ijms26115049.
5
Gut microbiota-derived butyrate mediates the anticolitic effect of indigo supplementation through regulating CD4 T cell differentiation.肠道微生物群衍生的丁酸盐通过调节CD4 T细胞分化介导靛蓝补充剂的抗结肠炎作用。
Imeta. 2025 Apr 19;4(3):e70040. doi: 10.1002/imt2.70040. eCollection 2025 Jun.
6
Characteristic gene expression profile of intestinal mucosa early in life promotes bacterial colonization leading to healthy development of the intestinal environment.生命早期肠道黏膜的特征性基因表达谱促进细菌定植,从而导致肠道环境的健康发育。
Sci Rep. 2025 May 26;15(1):18437. doi: 10.1038/s41598-025-03661-w.
7
The intestinal mucosa-associated microbiota in IBD-associated arthritis displays lower relative abundance of .炎症性肠病相关关节炎中肠道黏膜相关微生物群的相对丰度较低。 (注:原英文文本不完整,“of”后面缺少具体内容)
Gut Microbes. 2025 Dec;17(1):2505114. doi: 10.1080/19490976.2025.2505114. Epub 2025 May 18.
8
Toll-like Receptor Gene Polymorphisms as Predictive Biomarkers for Response to Infliximab in Japanese Patients with Crohn's Disease.Toll样受体基因多态性作为日本克罗恩病患者对英夫利昔单抗反应的预测生物标志物
Diagnostics (Basel). 2025 Apr 10;15(8):971. doi: 10.3390/diagnostics15080971.
9
Comparative analysis of gut microbiota in healthy and diarrheic foals.健康和腹泻马驹肠道微生物群的比较分析。
Microbiol Spectr. 2025 Mar 19;13(5):e0087124. doi: 10.1128/spectrum.00871-24.
10
Targeting CD4+ T cells through gut microbiota: therapeutic potential of traditional Chinese medicine in inflammatory bowel disease.通过肠道微生物群靶向CD4+ T细胞:中药在炎症性肠病中的治疗潜力
Front Cell Infect Microbiol. 2025 Mar 3;15:1557331. doi: 10.3389/fcimb.2025.1557331. eCollection 2025.